Indispensability of Pelvic and Paraaortic Lymphadenectomy in Endometrial Cancers
The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63...
Saved in:
Published in | Gynecologic oncology Vol. 64; no. 3; pp. 411 - 417 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
San Diego, CA
Elsevier Inc
01.03.1997
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63 patients with endometrial cancer who underwent simultaneous pelvic lymph node (PLN) and paraaortic lymph node (PAN) dissection between April 1988 and December 1995. Patients with stage Ia grade 1 and stage IV disease were excluded from this analysis. Both PLN and PAN metastases were found in 10.0% (4/40) of patients with stage I (FIGO, 1988) disease. Of 14 cases with PLN metastases, 8 (57.1%) had PAN metastases simultaneously, whereas 4 (8.2%) of 49 cases without PLN metastases had PAN metastases. There was no significant relationship between the sites or numbers of positive PLN and PAN metastases. Multivariate analysis revealed that poor grade and deep myometrial invasion had an independent relationship with PAN metastases, whereas vascular space invasion and cervical invasion were independently associated with PLN metastases. When divided into the groups of stage I–II and stage III, the prognosis of patients with RLN metastases was significantly poorer than that of patients without RLN metastases in each stage. Furthermore, survival of patients with PAN metastases was significantly worse compared with that of patients with only PLN metastases (44.4 and 80.0%, respectively,P< 0.05). These results reveal that PLN and PAN metastases occur frequently even in early-stage endometrial cancer, and that RLN metastases, especially PAN metastases, have a serious impact on patient survival. In conclusion, systemically simultaneous pelvic and paraaortic lymphadenectomy is essential for all the patients with endometrial cancer except those with stage Ia grade 1 and stage IV to provide prognostic information and select suitable postoperative treatment as well as to perform accurate FIGO staging, provided the condition of the patient permits. |
---|---|
AbstractList | The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63 patients with endometrial cancer who underwent simultaneous pelvic lymph node (PLN) and paraaortic lymph node (PAN) dissection between April 1988 and December 1995. Patients with stage Ia grade 1 and stage IV disease were excluded from this analysis. Both PLN and PAN metastases were found in 10.0% (4/40) of patients with stage I (FIGO, 1988) disease. Of 14 cases with PLN metastases, 8 (57.1%) had PAN metastases simultaneously, whereas 4 (8.2%) of 49 cases without PLN metastases had PAN metastases. There was no significant relationship between the sites or numbers of positive PLN and PAN metastases. Multivariate analysis revealed that poor grade and deep myometrial invasion had an independent relationship with PAN metastases, whereas vascular space invasion and cervical invasion were independently associated with PLN metastases. When divided into the groups of stage I-II and stage III, the prognosis of patients with RLN metastases was significantly poorer than that of patients without RLN metastases in each stage. Furthermore, survival of patients with PAN metastases was significantly worse compared with that of patients with only PLN metastases (44.4 and 80.0%, respectively, P < 0.05). These results reveal that PLN and PAN metastases occur frequently even in early-stage endometrial cancer, and that RLN metastases, especially PAN metastases, have a serious impact on patient survival. In conclusion, systemically simultaneous pelvic and paraaortic lymphadenectomy is essential for all the patients with endometrial cancer except those with stage Ia grade 1 and stage IV to provide prognostic information and select suitable postoperative treatment as well as to perform accurate FIGO staging, provided the condition of the patient permits. The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63 patients with endometrial cancer who underwent simultaneous pelvic lymph node (PLN) and paraaortic lymph node (PAN) dissection between April 1988 and December 1995. Patients with stage Ia grade 1 and stage IV disease were excluded from this analysis. Both PLN and PAN metastases were found in 10.0% (4/40) of patients with stage I (FIGO, 1988) disease. Of 14 cases with PLN metastases, 8 (57.1%) had PAN metastases simultaneously, whereas 4 (8.2%) of 49 cases without PLN metastases had PAN metastases. There was no significant relationship between the sites or numbers of positive PLN and PAN metastases. Multivariate analysis revealed that poor grade and deep myometrial invasion had an independent relationship with PAN metastases, whereas vascular space invasion and cervical invasion were independently associated with PLN metastases. When divided into the groups of stage I-II and stage III, the prognosis of patients with RLN metastases was significantly poorer than that of patients without RLN metastases in each stage. Furthermore, survival of patients with PAN metastases was significantly worse compared with that of patients with only PLN metastases (44.4 and 80.0%, respectively, P < 0.05). These results reveal that PLN and PAN metastases occur frequently even in early-stage endometrial cancer, and that RLN metastases, especially PAN metastases, have a serious impact on patient survival. In conclusion, systemically simultaneous pelvic and paraaortic lymphadenectomy is essential for all the patients with endometrial cancer except those with stage Ia grade 1 and stage IV to provide prognostic information and select suitable postoperative treatment as well as to perform accurate FIGO staging, provided the condition of the patient permits. |
Author | Sato, Shigemi Saito, Yoshiharu Yokoyama, Yoshihito Maruyama, Hidetoshi |
Author_xml | – sequence: 1 givenname: Yoshihito surname: Yokoyama fullname: Yokoyama, Yoshihito – sequence: 2 givenname: Hidetoshi surname: Maruyama fullname: Maruyama, Hidetoshi – sequence: 3 givenname: Shigemi surname: Sato fullname: Sato, Shigemi – sequence: 4 givenname: Yoshiharu surname: Saito fullname: Saito, Yoshiharu |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2606628$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9062142$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kE1r3DAQhkVISTcf194KPpTevB3Zliwdy5K2gYXuoT2LsT5SFVvaSt6A_31kdsmtp2F4nxlmnltyHWKwhHygsKUA_MvzEuKWSsm3HevbK7KhIFnNBZPXZAMgoRYNE-_Jbc5_AaAF2tyQGwm8oV2zIYenYHw-2pBx8KOflyq66mDHF68rDKY6YEKMaS7tfpmOf9DYYPUcp6XyoXoMJk52Th7HaodB25TvyTuHY7YPl3pHfn97_LX7Ue9_fn_afd3Xumu7uW5b6SR1UgzItTC9bhugwBkaJxwbWkZFhxK0M6AF1Y2zPR9KQtmAnUDa3pHP573HFP-dbJ7V5LO244jBxlNWvRB917MV3J5BnWLOyTp1TH7CtCgKalWoVoVqVahWhWXg42XzaZisecMvzkr-6ZJj1ji6VB73-Q1rOHDeiIKJM2aLhRdvk8ra2-LI-FQMKhP9_y54BbCij2s |
CODEN | GYNOA3 |
CitedBy_id | crossref_primary_10_1111_j_1525_1438_2003_13320_x crossref_primary_10_1016_j_ijgo_2007_03_035 crossref_primary_10_1097_IGC_0000000000000154 crossref_primary_10_3802_jgo_2010_21_4_209 crossref_primary_10_1097_IGC_0b013e3182094e09 crossref_primary_10_1016_j_gmit_2016_01_003 crossref_primary_10_1016_j_ygyno_2003_11_032 crossref_primary_10_1007_s12253_014_9893_4 crossref_primary_10_1007_s40134_014_0070_z crossref_primary_10_1016_j_suronc_2008_04_001 crossref_primary_10_1038_sj_bjc_6600468 crossref_primary_10_1111_aogs_12048 crossref_primary_10_1097_CCO_0b013e32833b9b75 crossref_primary_10_1016_j_ygyno_2012_10_008 crossref_primary_10_1016_S0304_3835_01_00803_5 crossref_primary_10_1155_2014_497478 crossref_primary_10_1016_j_ejso_2006_09_035 crossref_primary_10_1016_j_ygyno_2008_01_023 crossref_primary_10_1006_gyno_2000_6111 crossref_primary_10_3892_ol_2014_2653 crossref_primary_10_1016_j_addr_2009_04_015 crossref_primary_10_1093_jjco_28_11_673 crossref_primary_10_3802_jgo_2008_19_4_209 crossref_primary_10_1016_j_ygyno_2017_09_014 crossref_primary_10_3109_00016340903370114 crossref_primary_10_1016_j_ygyno_2004_07_025 crossref_primary_10_1016_j_ygyno_2009_03_032 crossref_primary_10_1097_IGC_0000000000001151 crossref_primary_10_1016_j_ygyno_2010_06_018 crossref_primary_10_1007_s00404_014_3330_5 crossref_primary_10_1016_j_ygyno_2010_12_001 crossref_primary_10_1155_2010_490219 crossref_primary_10_1016_j_ejogrb_2011_04_031 crossref_primary_10_1007_s00404_004_0668_0 crossref_primary_10_1007_s12253_012_9573_1 crossref_primary_10_1016_S0304_5013_06_72581_X crossref_primary_10_1080_01443615_2017_1281894 crossref_primary_10_1006_gyno_2000_6069 crossref_primary_10_1016_j_ygyno_2011_01_019 crossref_primary_10_1111_j_1525_1438_2006_00534_x crossref_primary_10_1002_jso_20479 crossref_primary_10_1016_j_tjog_2018_06_012 crossref_primary_10_3390_jcm10081746 crossref_primary_10_1148_radiology_212_3_r99au29711 crossref_primary_10_1111_jog_14953 crossref_primary_10_1006_gyno_1997_4929 crossref_primary_10_1007_s00761_008_1392_3 crossref_primary_10_1097_IGC_0b013e31821a3665 crossref_primary_10_1016_j_ygyno_2015_04_008 crossref_primary_10_1016_S0090_8258_03_00419_0 crossref_primary_10_1111_IGC_0b013e3181a7a2d9 crossref_primary_10_1177_1660_18154 crossref_primary_10_3802_jgo_2017_28_e59 crossref_primary_10_1245_s10434_010_1206_x crossref_primary_10_1006_gyno_2000_5802 crossref_primary_10_1007_s00404_016_4181_z crossref_primary_10_1586_era_12_157 crossref_primary_10_5180_jsgoe_31_417 crossref_primary_10_1053_ctrv_2000_0195 crossref_primary_10_1007_s10434_001_0723_z crossref_primary_10_1016_j_ygyno_2016_01_024 crossref_primary_10_1016_S1074_3804_05_60123_5 crossref_primary_10_1684_bdc_2009_0956 crossref_primary_10_1016_j_gmit_2016_04_001 crossref_primary_10_1016_j_ygyno_2010_05_004 crossref_primary_10_1007_s13224_012_0317_7 crossref_primary_10_1097_IGC_0b013e318249472d crossref_primary_10_1111_j_1525_1438_2006_00529_x crossref_primary_10_1016_j_ygyno_2010_11_026 crossref_primary_10_1016_S1470_2045_11_70070_5 crossref_primary_10_1016_j_bpobgyn_2015_02_007 crossref_primary_10_1016_S0140_6736_09_62002_X crossref_primary_10_1093_jjco_hyl066 crossref_primary_10_1097_RLU_0000000000001414 crossref_primary_10_1097_IGC_0000000000000120 crossref_primary_10_1007_s13193_014_0303_x crossref_primary_10_1016_j_tjog_2013_01_003 crossref_primary_10_1016_j_pog_2012_06_011 crossref_primary_10_1016_j_ygyno_2012_08_026 crossref_primary_10_1016_j_gyobfe_2010_08_016 crossref_primary_10_7863_jum_2007_26_7_949 crossref_primary_10_32322_jhsm_1208766 crossref_primary_10_1016_S0304_5013_07_73238_7 crossref_primary_10_1080_01443610410001660087 crossref_primary_10_1097_00001703_199802000_00005 crossref_primary_10_1097_GCO_0b013e32831ac3ac crossref_primary_10_1245_s10434_010_1472_7 crossref_primary_10_1245_s10434_018_6694_0 crossref_primary_10_1007_s00129_006_1929_8 crossref_primary_10_1046_j_1525_1438_2003_13023_x |
ContentType | Journal Article |
Copyright | 1997 Academic Press 1997 INIST-CNRS |
Copyright_xml | – notice: 1997 Academic Press – notice: 1997 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1006/gyno.1996.4573 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1095-6859 |
EndPage | 417 |
ExternalDocumentID | 10_1006_gyno_1996_4573 9062142 2606628 S0090825896945734 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29I 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAXUO ABBQC ABFNM ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IH2 IHE J1W K-O KOM L7B LCYCR LG5 M29 M41 MO0 N9A O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- 08R AAPBV AAUGY ABPIF ABPTK IQODW AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c434t-339f91f98ba6c8d7c3201065adf8f5b35184a90cfd0c81c2fe76b8f515ba48a13 |
IEDL.DBID | .~1 |
ISSN | 0090-8258 |
IngestDate | Thu Oct 24 23:51:34 EDT 2024 Thu Sep 26 18:58:56 EDT 2024 Sat Sep 28 07:36:30 EDT 2024 Sun Oct 29 17:08:46 EDT 2023 Fri Feb 23 02:26:03 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Carcinoma Prognosis Stage classification Malignant tumor Metastasis Female genital diseases Lymphadenectomy Pelvic ganglion Surgery Uterine diseases Paraaortic ganglion Endometrium |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c434t-339f91f98ba6c8d7c3201065adf8f5b35184a90cfd0c81c2fe76b8f515ba48a13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 9062142 |
PQID | 78874751 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_78874751 crossref_primary_10_1006_gyno_1996_4573 pubmed_primary_9062142 pascalfrancis_primary_2606628 elsevier_sciencedirect_doi_10_1006_gyno_1996_4573 |
PublicationCentury | 1900 |
PublicationDate | 1997-03-01 |
PublicationDateYYYYMMDD | 1997-03-01 |
PublicationDate_xml | – month: 03 year: 1997 text: 1997-03-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | San Diego, CA |
PublicationPlace_xml | – name: San Diego, CA – name: United States |
PublicationTitle | Gynecologic oncology |
PublicationTitleAlternate | Gynecol Oncol |
PublicationYear | 1997 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
SSID | ssj0003012 |
Score | 1.8989164 |
Snippet | The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 411 |
SubjectTerms | Adult Aged Aorta, Abdominal Biological and medical sciences Endometrial Neoplasms - mortality Endometrial Neoplasms - pathology Endometrial Neoplasms - surgery Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Lymph Node Excision - methods Lymphatic Metastasis Medical sciences Middle Aged Multivariate Analysis Prognosis Retroperitoneal Neoplasms - mortality Retroperitoneal Neoplasms - secondary Retroperitoneal Neoplasms - surgery Retrospective Studies Risk Factors Survival Rate Tumors |
Title | Indispensability of Pelvic and Paraaortic Lymphadenectomy in Endometrial Cancers |
URI | https://dx.doi.org/10.1006/gyno.1996.4573 https://www.ncbi.nlm.nih.gov/pubmed/9062142 https://search.proquest.com/docview/78874751 |
Volume | 64 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBYhhVAopa9Qt02iQ6Cnjb3WY6VjMAlO3ARTGpqbGO1KxdBoje0cfOlv78w-UnLwpaeFXYYV34xGI2nmG8ZOCx9F9L7KMJhXmTRSZaCUyHQwAjC8D7Y5zLm51dM7eX2v7vfYpK-FobTKzve3Pr3x1t2bYYfmcLlYUI0vtetWxmorVSGIE1Ti8oc2ffbnX5oHGnDLGN6UTCvTEzeO9PDXNtVUrafPSH7XwvRqCWuEK7Z9LnYHos2CdPmGve4iSX7eDvYt2wvpHTu46e7K37P5VaoW6yVuU1sq7i2vI5-H3-gaOKSKz2EFUJM0_7ZFnQJ6IDrCf9jyReIXqaofQtPTg0_IMlbrD-zu8uLHZJp1_ROyUgq5yYSw0ebRGg-6NFVRCrr61gqqaKLyQuHuDuyojNWoNHk5jqHQHr_kyoM0kItDtp_qFD4ybsGXuY6qjBgPxIjaFQBWyUICygg9YF978NyypclwLSGydgSzI5gdwTxgeY-te6Zohz58p8zRMyU8_WJM26-xGbCTXikOZwddeUAK9ePaUa6kLFQ-YIetrp5EiZ85l-NP_zGcz-xlS2JLmWhf2P5m9RiOMDTZ-OPG9o7Zi_Or2fSWnrPvP2d_AaRq5cY |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6DtgGDMNexdKtqw4DdnITRw9LxyFokW5JkUML9CbQtjQEWOUgSQ-57LdXtOwOPeSyqw3KwkeaoiTyI8C3ovTcl2WdxWBeZkILmaGUPFNOc4zhvTPtYc78Sk1vxM9beXsAk74WhtIqO9-ffHrrrbsnww7N4Wq5pBpfatcttVFGyIKLZ_BcUHwcjfrs7788j2jBiTK8rZmWumduHKnh711oqFxPndEA-1am1yvcRLx8anSxPxJtV6SLt_CmCyXZjzTbd3Dgwnt4Me8uyz_A4jLUy80q7lMTF_eONZ4t3J_oGxiGmi1wjdiQNJvtolIxuiA6w7_bsWVg56Fu7lzb1INNyDTWm49wc3F-PZlmXQOFrBJcbDPOjTe5N7pEVem6qDjdfSuJtddellzG7R2aUeXrUaXzauxdocr4JpclCo05P4LD0AT3CZjBssqVl5WPAYH3Ub0c0UhRCIwyXA3gew-eXSWeDJsYkZUlmC3BbAnmAeQ9tvaJpm104ntlTp4o4fETY9p_jfUATnul2Ph70J0HBtfcbywlS4pC5gM4Srp6FCWC5lyMj_9jOqfwcno9n9nZ5dWvz_AqMdpSWtoXONyu791JjFO25dfWDh8A4uzlvA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Indispensability+of+pelvic+and+paraaortic+lymphadenectomy+in+endometrial+cancers&rft.jtitle=Gynecologic+oncology&rft.au=Yokoyama%2C+Y&rft.au=Maruyama%2C+H&rft.au=Sato%2C+S&rft.au=Saito%2C+Y&rft.date=1997-03-01&rft.issn=0090-8258&rft.volume=64&rft.issue=3&rft.spage=411&rft_id=info:doi/10.1006%2Fgyno.1996.4573&rft_id=info%3Apmid%2F9062142&rft.externalDocID=9062142 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-8258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-8258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-8258&client=summon |